Pennystocksupdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 09/03/2013 -- Pennystocksupdate.biz issues special report on - Towerstream Corporation, Arena Pharmaceuticals Inc.
Towerstream Corporation (NASDAQ:TWER) provides broadband services to commercial customers and delivers access over a wireless network transmitting over both regulated and unregulated radio spectrum. The Company's service supports bandwidth on demand, wireless redundancy, virtual private networks (VPNs), disaster recovery, bundled data and video services.
Towerstream Corporation ’s (TWER) share price has entered into oversold territory with an RSI value of 29.75. The Zacks Consensus Estimate on Towerstream Corporation’s loss for the full year period have moved lower by 2 cents over the past two months to $0.37 per share. Currently, Towerstream Corporation is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (TWER) after its recent drop.
Should Investor Buy OR Sell This Stock : CLICK HERE.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is making improvement, shifting its direction nearer to making money for the organization. On Wed, Field said it finished a stage 1b test for APD811, a treatment for lung arterial hypertension, a way of hypertension.
The test was only in healthier volunteers, but it seems to have met its objectives for protection, tolerability, and pharmacokinetics, which actions how much of the medication is taken up by the body and how easily it's eliminated.
The next step is for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) to start a stage 2 test in sufferers with lung arterial hypertension. We may see two stage 2 tests, one to try and fingernail down the appropriate amount and then a second with more sufferers at the amount the organization programs to use for stage 3 tests. Sometimes they're run as one stage 2a/b test.
Should this stock be a buy , hold or sell? Let us help you decide, Check here.
Neither Pennystocksupdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Pennystocksupdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Pennystocksupdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Pennystocksupdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)